- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Edema blisters.
Displaying page 1 of 1.
EudraCT Number: 2007-004304-12 | Sponsor Protocol Number: 2260/2006 | Start Date*: 2007-09-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Pilot study, randomised, open-label, monocentre, case vs control study to assess the effect of topically and parenterally Heparin administration treatment in superficial and deep second grade bu... | |||||||||||||
Medical condition: Superficial and deep second degree burns. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001097-27 | Sponsor Protocol Number: MONO-01 | Start Date*: 2005-09-29 |
Sponsor Name:Bio-Gels Pharmaceuticals | ||
Full Title: A Study of the Clinical Activity of Monocaprin/Doxycycline Gel on Cold Sores | ||
Medical condition: Herpes simplex virus (HSV) has plagued mankind worldwide for thousands of years. Once HSV enters the body, it penetrates vulnerable cells in the lower layers of human skin tissue and replicates its... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IS (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002249-53 | Sponsor Protocol Number: P150924 | Start Date*: 2023-02-16 | |||||||||||
Sponsor Name:Assistance Publique - Hôpitaux de Paris (AP-HP) | |||||||||||||
Full Title: Comparing short to standard amoxicillin course for eRysipElas: a non-inferiority randomized controlled trial | |||||||||||||
Medical condition: Adults diagnosed with lower limbs erysipelas/ cellulitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001125-15 | Sponsor Protocol Number: ATB-202 | Start Date*: 2018-07-16 | |||||||||||||||||||||
Sponsor Name:Atox Bio | |||||||||||||||||||||||
Full Title: Phase III, randomized, double-blind, placebo controlled, parallel-group, study of AB103 as compared to placebo in patients with necrotizing soft tissue infections (NSTI) | |||||||||||||||||||||||
Medical condition: Necrosis of soft tissue infections (NSTI) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
